However, there are factors that need to be considered
14 A 2017 meta-analysis of 52 randomized, controlled trials that evaluated DPP-4 inhibitors' effects on beta-cell function found that, in monotherapy studies, all agents except linagliptin resulted in improvements in cell function
Even though the procedure is considered safe, there are some risks and side effects because of the fact that it bypasses all of your bodys gatekeeping functions
We strongly advise against this approach
Retatrutide is a single-molecule triple agonist: It activates GIP, GLP-1, and glucagon receptors in one peptide
GLP-1 medications should not be taken by anyone with a personal history or family history of medullary thyroid cancer, as development of these tumors were noted during early animal studies